May 8, 2014 / 10:20 AM / in 4 years

Valeant Pharmaceuticals posts smaller loss

May 8 (Reuters) - Valeant Pharmaceuticals International Inc , Canada’s largest listed drugmaker, reported a smaller quarterly loss, helped by robust sales in the United States.

The company’s net loss narrowed to $20.3 million, or 7 cents per share, in the first quarter ended March 31 from $27.5 million, or 9 cents per share, a year earlier.

Cash earnings, or profit adjusted for one-time items, jumped 35 percent to $600 million, or $1.76 per share.

Total revenue rose 77 percent to $1.89 billion. (Reporting by Ashutosh Pandey in Bangalore; Editing by Sriraj Kalluvila)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below